Seres Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Seres Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Seres Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Seres Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $244k | 13k | 19.24 |
| 2025-06-30 | $84k | 7.5k | 11.11 |